Literature DB >> 2387294

In vitro susceptibility of Aeromonas caviae, Aeromonas hydrophila and Aeromonas sobria to fifteen antibacterial agents.

A Burgos1, G Quindós, R Martínez, P Rojo, R Cisterna.   

Abstract

In vitro testing of the activity of 15 antibacterial agents against 522 clinical isolates of Aeromonas species demonstrated some species-associated trends. Amoxicillin plus clavulanic acid was effective against approximately 45% of Aeromonas caviae and Aeromonas hydrophila, but all Aeromonas sobria isolates were resistant. Aztreonam, piperacillin and mezlocillin were highly active against all the strains of Aeromonas tested. Ticarcillin was equally effective against Aeromonas caviae and Aeromonas hydrophila, but more than 50% of Aeromonas sobria isolates were resistant. The latter species was more susceptible to cephalosporins than Aeromonas hydrophila and Aeromonas caviae. Chloramphenicol, tetracycline and trimethoprim-sulfamethoxazole were extremely active against all three Aeromonas species, likewise ofloxacin and ciprofloxacin. Aztreonam, third-generation cephalosporins, chloramphenicol and the quinolones can thus be considered for therapy of infections when Aeromonas is implicated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2387294     DOI: 10.1007/bf01979472

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  In-vitro susceptibility of Aeromonas app. to antimicrobial agents.

Authors:  C J Richardson; J O Robinson; L B Wagener; V Burke
Journal:  J Antimicrob Chemother       Date:  1982-04       Impact factor: 5.790

2.  Isolation of drug-resistant Aeromonas hydrophila from aquatic environments.

Authors:  L A McNicol; K M Aziz; I Huq; J B Kaper; H A Lockman; E F Remmers; W M Spira; M J Voll; R R Colwell
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

3.  In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.

Authors:  V Fainstein; S Weaver; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

4.  Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.

Authors:  J S Bakken; C C Sanders; R B Clark; M Hori
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

5.  Cephalothin susceptibility as a potential marker for the Aeromonas sobria group.

Authors:  J M Janda; M R Motyl
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

6.  Biochemical characteristics, enterotoxigenicity and susceptibility to antimicrobial agents of clinical isolates of Aeromonas species encountered in the western region of Saudi Arabia.

Authors:  P J Gosling
Journal:  J Med Microbiol       Date:  1986-08       Impact factor: 2.472

7.  Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides.

Authors:  J F Reinhardt; W L George
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

8.  Antimicrobial susceptibility of sixty human fecal isolates of Aeromonas species.

Authors:  E J Kuijper; M F Peeters; B S Schoenmakers; H C Zanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

9.  Resistance of Aeromonas hydrophila to beta-lactam antibiotics.

Authors:  R Zemelman; C Gonzalez; M A Mondaca; J Silva; C Merino; M Dominguez
Journal:  J Antimicrob Chemother       Date:  1984-12       Impact factor: 5.790

10.  In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents.

Authors:  M R Motyl; G McKinley; J M Janda
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

  10 in total
  6 in total

1.  Which antibiotics and breakpoints should be used for Aeromonas susceptibility testing? Considerations from a comparison of agar dilution and disk diffusion methods using Enterobacteriaceae breakpoints.

Authors:  B Lamy; F Laurent; A Kodjo; F Roger; E Jumas-Bilak; H Marchandin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-27       Impact factor: 3.267

2.  In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents.

Authors:  J M Koehler; L R Ashdown
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

3.  Occurrence of antimicrobial resistance in fish-pathogenic and environmental bacteria associated with four danish rainbow trout farms.

Authors:  A S Schmidt; M S Bruun; I Dalsgaard; K Pedersen; J L Larsen
Journal:  Appl Environ Microbiol       Date:  2000-11       Impact factor: 4.792

4.  In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.

Authors:  Wen-Chien Ko; Shyh-Ren Chiang; Hsin-Chun Lee; Hung-Jen Tang; Yin-Yi Wang; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

5.  Different clinical characteristics among Aeromonas hydrophila, Aeromonas veronii biovar sobria and Aeromonas caviae monomicrobial bacteremia.

Authors:  Han-Chuan Chuang; Yu-Huai Ho; Chorng-Jang Lay; Lih-Shinn Wang; Yeong-Shu Tsai; Chen-Chi Tsai
Journal:  J Korean Med Sci       Date:  2011-10-27       Impact factor: 2.153

6.  Septicemia due to Aeromonas hydrophila in a pregnant woman: a case report and review of the literature.

Authors:  R F Damián; R V Zesati; L S Fernáindez; J L García
Journal:  Infect Dis Obstet Gynecol       Date:  1995
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.